Published in OBGYN and Reproduction Week, March 22nd, 2010
"Moreover, all major phase III trials involving aromatase inhibitors in the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of OBGYN and Reproduction Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.